Katia Balmas Bourloud

Author PubWeight™ 7.27^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.	PLoS One	2007	1.09
2	Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.	Mol Cancer	2008	1.04
3	Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.	Oncogene	2004	1.03
4	Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.	Oncogene	2002	0.94
5	Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.	BMC Cancer	2006	0.87
6	Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.	Oncotarget	2014	0.83
7	Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.	Genes Chromosomes Cancer	2006	0.81
8	Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma.	Genes Chromosomes Cancer	2003	0.80